Cumberland Pharmaceuticals (CPIX) Tops Q4 EPS and Revenue

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, $0.26 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $10.98 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Summit Hotel Properties refinances $650M credit facility through 2031
• Eversource completes $2.4B sale of Aquarion Water Company